News
Media
Multimedia Series
Conferences
Partners
CME/CE
Resources
Advisory Board
Subscribe

Spotlight -

This Year In Medicine 2025

June 2005

Do ACE inhibitors have antiarrhythmic properties?

By

June 18th 2005

Part 3: Overview of study designs

By

June 17th 2005

Inflammatory markers and the risk of coronary heart disease

By

June 15th 2005

Statin therapy in heart failure

By

June 14th 2005

Inflammatory markers versus lipid levels in the risk of CAD

By

June 13th 2005

ACE inhibition and atrial fibrillation: Improving the substrate

By

June 11th 2005

A hypertensive patient with atrial fibrillation

By

June 9th 2005

Reducing the incidence of atrial fibrillation by inhibiting angiotensin-converting enzyme

By

June 8th 2005

Dual antiplatelet therapy superior to monotherapy in reducing embolization in stroke patients

By

June 6th 2005

Fish oil supplements may lower cardiac risk by increasing heart rate variability

By

June 4th 2005

Expert panel: African Americans deserve greater statin access

By

June 2nd 2005

Catheter ablation reduces AF recurrences

By

June 1st 2005

Trending on HCPLive

Teplizumab Receives Accelerated FDA Approval for Stage 3 T1D in Children

Heart Failure Congress 2026 Highlights, with Manreet Kanwar, MD

How to Approach Chronic Urticaria from Allergist and Dermatologist Perspectives

FDA Clears First OTC Glucose Monitor for Children

Can Supplements Help to Address Acne? With Steven Daveluy, MD